skip to Main Content
  • This page as PDF

Benchmark Survey Results


A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.


Matt Brow , President & General Manager - Pharmacy, Life Sciences & Advisory, Avalere Executive

Matt Brow is president and general manager of Avalere Health, Inovalon's data-driven advisory business.

Back To Top